Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Minocycline
Drug ID BADD_D01470
Description Minocycline was first described in the literacture in 1966.[A190681] It is a second generation tetracycline antibiotic that is active against gram-negative and gram-positive bacteria.[A190723] Like other semisynthetic tetracyclines, minocycline has modifications to carbons 7-9 on the D ring to generate higher efficacy than previous tetracyclines.[A190723] Minocycline was granted FDA approval on 30 June 1971.[L11695]
Indications and Usage For the treatment of infections caused by susceptible strains of microorganisms, such as Rocky Mountain spotted fever, typhus fever and the typhus group, Q fever, rickettsial pox and tick fevers caused by Rickettsiae, upper respiratory tract infections caused by Streptococcus pneumoniae and for the treatment of asymptomatic carriers of Neisseria meningitidis.
Marketing Status Prescription; Discontinued
ATC Code A01AB23; D10AF07; J01AA08
DrugBank ID DB01017
KEGG ID D05045
MeSH ID D008911
PubChem ID 54675783
TTD Drug ID D08LTU
NDC Product Code 42291-591; 42291-589; 69489-201; 72356-101; 49884-512; 72356-103; 63629-2228; 49884-513; 63629-2229; 49884-511
Synonyms Minocycline | Minox 50 | Aknemin | Aknin-Mino | Aknin Mino | Aknosan | Mynocine | Apo-Minocycline | Apo Minocycline | Arestin | Blemix | Cyclomin | Cyclops | Dentomycin | Dynacin | Icht-Oral | Icht Oral | Klinomycin | Lederderm | Mestacine | Minakne | Mino-Wolff | Mino Wolff | Minocin | Minocin MR | Minoclir | Minocycline Hydrochloride | Hydrochloride, Minocycline | Minocycline Monohydrochloride | Monohydrochloride, Minocycline | Minocycline, (4R-(4 alpha,4a beta,5a beta,12a beta))-Isomer | Minolis | Minomycin | Minoplus | Minotab | Akamin | Akne-Puren | Akne Puren
Chemical Information
Molecular Formula C23H27N3O7
CAS Registry Number 10118-90-8
SMILES CN(C)C1C2CC3CC4=C(C=CC(=C4C(=C3C(=O)C2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Adverse drug reactionCytochrome P450 2E1P05181Not Available1421660; 3224399; 1814842
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Asthenia08.01.01.001--Not Available
Asthma10.01.03.010; 22.03.01.002--Not Available
Ataxia08.01.02.004; 17.02.02.0010.000518%
Atrial fibrillation02.03.03.002--
Atrioventricular block first degree02.03.01.0040.000777%
Autoimmune hepatitis10.04.09.001; 09.01.07.0190.010097%Not Available
Back pain15.03.04.005--
Bacteraemia11.01.11.0010.001036%
Balanoposthitis21.09.03.001--Not Available
Basedow's disease05.02.02.003; 10.04.08.004; 06.09.04.0030.001036%Not Available
Benign intracranial hypertension17.07.02.0010.004401%Not Available
Biopsy thyroid gland abnormal13.10.08.001--Not Available
Blindness17.17.01.003; 06.02.02.0010.001812%Not Available
Blister23.03.01.001; 12.01.06.002--Not Available
Blood bilirubin increased13.03.01.0080.001036%
Blood calcium increased13.11.01.0030.000518%Not Available
Blood chloride decreased13.11.01.0040.000777%Not Available
Blood cholesterol increased13.12.01.0020.001036%
Blood creatine phosphokinase increased13.04.01.001--
Blood creatinine increased13.13.01.0040.001294%
Blood potassium decreased13.11.01.0100.000518%Not Available
Blood pressure decreased13.14.03.002--Not Available
Blood pressure increased13.14.03.005--Not Available
Blood sodium decreased13.11.01.0120.000518%Not Available
Blood triglycerides increased13.12.03.0010.001036%Not Available
Blood urea increased13.13.01.006--Not Available
Bone development abnormal15.02.04.003--Not Available
Bone disorder15.02.04.0040.001294%Not Available
Bone pain15.02.01.001--
Brain stem infarction24.04.06.014; 17.08.01.0240.000518%Not Available
The 2th Page    First    Pre   2 3 4 5 6    Next   Last    Total 16 Pages